Federal Circuit Says ‘Target’ Correctly Construed In Drug Patent Dispute
WASHINGTON, D.C. — A finding by a federal judge in New Jersey that two patents relating to the drug Vimovo are invalid was affirmed Jan. 6 by the Federal Circuit U.S....To view the full article, register now.
Already a subscriber? Click here to view full article